KSRP: a checkpoint for inflammatory cytokine production in astrocytes.
KSRP: a checkpoint for inflammatory cytokine production in astrocytes.
复制标题
DOI:
10.1002/glia.22396
复制
发表时间:
2012-11
期刊:
影响因子:
6.2
通讯作者:
King, Peter H.
中科院分区:
文献类型:
--
作者:
Li, Xuelin;Lin, Wei-Jye;Chen, Ching-Yi;Si, Ying;Zhang, Xiaowen;Lu, Liang;Suswam, Esther;Zheng, Lei;King, Peter H.
Chronic inflammation in the central nervous system (CNS) is a central feature of many neurodegenerative and autoimmune diseases. As an immunologically competent cell, the astrocyte plays an important role in CNS inflammation. It is capable of expressing a number of cytokines such as tumor necrosis factor alpha (TNF-α) and interleukin-1 beta (IL-1β) that promote inflammation directly and through the recruitment of immune cells. Checkpoints are therefore in place to keep tight control over cytokine production. Adenylate/uridylate-rich elements (ARE) in the 3′ untranslated region of cytokine mRNAs serve as a major checkpoint by regulating mRNA stability and translational efficiency. Here, we examined the impact of KH-type splicing regulatory protein (KSRP), an RNA binding protein which destabilizes mRNAs via the ARE, on cytokine expression and paracrine phenotypes of primary astrocytes. We identified a network of inflammatory mediators, including TNF-α and IL-1β, whose expression increased 2 to 4-fold at the RNA level in astrocytes isolated from KSRP−/− mice compared to littermate controls. Upon activation, KSRP−/− astrocytes produced TNF-α and IL-1β at levels that exceeded control cells by 15-fold or more. Conditioned media from KSRP−/− astrocytes induced chemotaxis and neuronal cell death in vitro. Surprisingly, we observed a prolongation of half-life in only a subset of mRNA targets and only after selective astrocyte activation. Luciferase reporter studies indicated that KSRP regulates cytokine gene expression at both transcriptional and post-transcriptional levels. Our results outline a critical role for KSRP in regulating pro-inflammatory mediators and have implications for a wide range of CNS inflammatory and autoimmune diseases.
登录
查看更多内容
DOI:
10.1016/j.bbrc.2006.05.093
发表时间:
2006-07-21
影响因子:
3.1
作者:
Chen, Yu-Ling;Huang, Ya-Lin;Chang, Ching-Jin
通讯作者:
Chang, Ching-Jin
影响因子:
5.5
作者:
Aoki, Naoko;Kimura, Yuka;Tateno, Masatoshi
通讯作者:
Tateno, Masatoshi
影响因子:
5.3
作者:
Chung, Hye-Jung;Liu, Juhong;Levens, David
通讯作者:
Levens, David
影响因子:
64.8
作者:
Chen, Szu-Ting;Lin, Yi-Ling;Hsieh, Shie-Liang
通讯作者:
Hsieh, Shie-Liang
影响因子:
64.8
作者:
Bouchon, A;Facchetti, F;Colonna, M
通讯作者:
Colonna, M